Emory's Dr. Allan D. Kirk speaks on "Memory Cells and Rejection: Improving Transplant Results." A conversation on recent breakthroughs in transplant that are likely to allow transplant specialists to indidividualize patient treatment. Specialists are now able to assess a patient's individual propensity to accept or reject a transplant, based on their body mix of "memory cells" and "naive cells," and then adjust the treatment before and after treatment accordingly.
More Information
"Post-Transplant Combo Can Replace Toxic Immune-Suppressing Drugs in Monkeys"
http://whsc.emory.edu/home/news/releases/2009/07/post-transplant-combo-replac...
Emory Transplant Center
http://transplant.emory.edu
Woodruff Health Sciences Center, Emory University
http://www.emoryhealthsciences.org
thanks. This helps.
elvishggpirate 2 years ago